Venlafaxine: Difference between revisions
Jump to navigation
Jump to search
imported>Robert Badgett (New page: In medicine and psychiatry, '''venlafaxine''' is a second generation antidepressant that is a a norepinephrine reuptake inhibitor<ref>{{MeSH}}</ref> ==History== Effexor br...) |
imported>Howard C. Berkowitz No edit summary |
||
| Line 1: | Line 1: | ||
In [[medicine]] and [[psychiatry]], '''venlafaxine''' is a [[second generation antidepressant]] that | {{subpages}} | ||
In [[medicine]] and [[psychiatry]], '''venlafaxine''' is a [[second generation antidepressant]] that has unusual chemistry: it inhibits the reuptake of several [[neurotransmitter]]s depending on dose. | |||
==History== | ==History== | ||
Effexor brand of venlafaxine was approved by the [[Food and Drug Administration]] in the [[United States]] with a [http://www.fda.gov/Drugs/DevelopmentApprovalProcess/HowDrugsareDevelopedandApproved/ApprovalApplications/NewDrugApplicationNDA/ New Drug Application] (NDA) in 1993.<ref>{{FDA-Drug_Details|020151}}</ref> A generic version was approved with a NDA in 2008.<ref>{{FDA-Drug_Details|022104}}</ref> | '''Effexor''' brand of venlafaxine was approved by the [[Food and Drug Administration]] in the [[United States]] with a [http://www.fda.gov/Drugs/DevelopmentApprovalProcess/HowDrugsareDevelopedandApproved/ApprovalApplications/NewDrugApplicationNDA/ New Drug Application] (NDA) in 1993.<ref>{{FDA-Drug_Details|020151}}</ref> A generic version was approved with a NDA in 2008.<ref>{{FDA-Drug_Details|022104}}</ref> | ||
Generic versions of the time-release form are also available. | |||
==Pharmacology== | ==Pharmacology== | ||
| Line 10: | Line 13: | ||
===Excretion=== | ===Excretion=== | ||
===Toxicity=== | ===Toxicity=== | ||
==External links== | ==External links== | ||
Revision as of 21:35, 21 August 2010
In medicine and psychiatry, venlafaxine is a second generation antidepressant that has unusual chemistry: it inhibits the reuptake of several neurotransmitters depending on dose.
History
Effexor brand of venlafaxine was approved by the Food and Drug Administration in the United States with a New Drug Application (NDA) in 1993.[1] A generic version was approved with a NDA in 2008.[2]
Generic versions of the time-release form are also available.
Pharmacology
Administration
Distribution
Metabolism
Excretion
Toxicity
External links
The most up-to-date information about Venlafaxine and other drugs can be found at the following sites.
- Venlafaxine - FDA approved drug information (drug label) from DailyMed (U.S. National Library of Medicine).
- Venlafaxine - Drug information for consumers from MedlinePlus (U.S. National Library of Medicine).
- Venlafaxine - Detailed information from DrugBank.
References
- ↑ Anonymous. Drugs@FDA for FDA Application No. 020151. U S Food and Drug Administration
- ↑ Anonymous. Drugs@FDA for FDA Application No. 022104. U S Food and Drug Administration